Are Freeze-Dried Antibodies The Future of Medicine?

Stabilized dry antibodies could serve as the next great leap in treating diseases ranging from Covid-19 to cancer.

Jesse Smith, MD
BeingWell

--

Monoclonal antibody therapies were one of the great medical achievements in the 20th century. As antibody manufacturing technologies became available, researchers were given the power to create an antibody capable of binding nearly any target in the body. This revolutionized the way the diseases such as cancer are treated. However, for all of their upsides, monoclonal antibody therapies remain both expensive and difficult to administer on a larger scale. Stabilized, dry versions of monoclonal antibodies may knock down those barriers and harness a new potential in the treatment of disease.

Early in 2020 as the Covid-19 outbreak began to gain traction across the globe, attention turned to antibody therapies as a means of treating the disease. These therapies work off the theory that infusing artificial antibodies into circulation would confer the same protection that natural antibodies would against the SARS-CoV-2 virus.

Transferring Immunity

Initially, health care workers turned to convalescent plasma — the liquid fraction of blood extracted from people who have recovered from…

--

--

Jesse Smith, MD
BeingWell

Physician and molecular biologist. I write about topics in science and medicine that relate to everyone.